Cellectis
CLLS
#7381
Rank
โ‚น39.26 B
Marketcap
โ‚น391.34
Share price
5.05%
Change (1 day)
189.00%
Change (1 year)

Market capitalization of Cellectis (CLLS)

Market cap: โ‚น39.26 Billion

As of December 2025 Cellectis has a market cap of โ‚น39.26 Billion. This makes Cellectis the world's 7381th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cellectis from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น39.26 B218.17%
2024โ‚น12.33 B-32.77%
2023โ‚น18.35 B126.65%
2022โ‚น8.09 B-71.6%
2021โ‚น28.51 B-69.42%
2020โ‚น93.24 B75.32%
2019โ‚น53.18 B3.93%
2018โ‚น51.17 B-20.48%
2017โ‚น64.35 B56.41%
2016โ‚น41.14 B-42.34%
2015โ‚น71.36 B157.11%
2014โ‚น27.75 B570.96%
2013โ‚น4.13 B

End of Day market cap according to different sources

On Dec 18th, 2025 the market cap of Cellectis was reported to be:

โ‚น26.85 Billion
by Nasdaq info icon info icon
โ‚น37.37 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
uniQure
QURE
โ‚น133.82 B 240.85%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Novavax
NVAX
โ‚น96.91 B 146.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น7.289 T 18,465.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
โ‚น41.09 B 4.68%๐Ÿ‡บ๐Ÿ‡ธ USA